3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Glioblastoma
21
Brain Neoplasms
9
Medulloblastoma
7
Central Nervous System Neoplasms
7
Lymphoma
6
Glioma
6
Astrocytoma
5
Oligodendroglioma
4
Recurrence
3
Gliosarcoma
3
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Ependymoma
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Newly Diagnosed High Grade Glioma
1
Neuroectodermal Tumors, Primitive
1
Neuroectodermal Tumors
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, AIDS-Related
1
Lung Neoplasms
1
Intraocular Lymphoma
1
Familial ependymoma
1
Drug-Related Side Effects and Adverse Reactions
1
Interventions
Rituximab
15
Cyclophosphamide
15
Peripheral Blood Stem Cell Transplantation
14
fludarabine phosphate
11
Whole-Body Irradiation
11
Mycophenolic Acid
8
Etoposide
8
Methotrexate
7
Filgrastim
7
Cyclosporine
7
Lenalidomide
6
Dexamethasone
6
Busulfan
6
Tacrolimus
5
Radiotherapy
5
Cytarabine
5
Carboplatin
5
Thiotepa
4
Melphalan
4
Transplantation
3
Therapeutics
3
Granulocyte Colony-Stimulating Factor
3
Flow Cytometry
3
Calcium Dobesilate
3
Bortezomib
3
Antilymphocyte Serum
3
pegfilgrastim
2
etoposide phosphate
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Intraocular Lymphoma
×
Lomustine
×
Clear all
NCT00074191
2017-04-21
Protocol-A
OHSU Knight Cancer Institute
Phase 2
Completed
1 enrolled